The majority of key cytokines involved in AML and MM pathogenesis have been shown to activate the PI3K pathway within the bone marrow microenvironment, accounting for the aberrant activation observed in patient samples where no somatic mutations are present. The gene discussed is PIK3CA; the disease is acute myeloid leukemia.